New UKGTN Genetic Test Recommendations for NHS Service approved by the Clinical & Scientific Advisory Group March 2015
1 July 2015
The UKGTN Clinical and Scientific Advisory Group (CSAG) met on 17th March 2015 and recommended 11 new tests for NHS service:
- 10 are prescribed services and 1 is within Highly Specialised
- 7 were evaluated through the very rare disease process (less than 20 index cases a year and less than £5000 annual costs for index cases)
- all 11new tests are panel tests that use Next Generation Sequencing (NGS)
Please access the summary report for further details of these recommendations including a list of the tests, clinical benefits and financial implications. Potential savings are a mix of actual savings (e.g. NGS tests replacing Sanger sequencing tests) and efficiencies as they release capacity for alternative use in the NHS (e.g. MRI no longer required for a patient that can have the genetic test instead). The testing services will be added to the online database of tests along with the Testing Criteria and Gene Dossiers.